Continuous intravenous infusions of famotidine maintain high intragastric pH in duodenal ulcer
- PMID: 3286384
- PMCID: PMC1433542
- DOI: 10.1136/gut.29.4.453
Continuous intravenous infusions of famotidine maintain high intragastric pH in duodenal ulcer
Abstract
Three double blind crossover studies were carried out to assess the ability of primed infusions of famotidine to raise intragastric pH over 24 hours in 12 duodenal ulcer patients. pH was measured continuously using intragastric electrodes and solid state recording devices. The studies compared the effects of placebo, famotidine 10 mg bolus injection iv followed by continuous infusions of 3.2 mg/h and 4 mg/h in random order. Gastric acidity decreased significantly with both dose regimens (p less than 0.0005) but the effects of either dosage were similar. During fasting median pH rose from 1.35 to 7.1 and 7.05 respectively. During the day, when standard meals were taken, median pH rose from 1.30 to 4.3 and 3.65 respectively. Despite continuous infusions the H2-antagonist was less effective during this time. The latter finding raises questions about gastric secretory control during the day when food is eaten.
Similar articles
-
Continuous 24-hour intragastric pH monitoring in the evaluation of the effect of a nightly dose of famotidine, ranitidine and placebo on gastric acidity of patients with duodenal ulcer.Digestion. 1987;37(2):103-9. doi: 10.1159/000199475. Digestion. 1987. PMID: 3305114 Clinical Trial.
-
A comparison of the effects on intragastric acidity of bedtime or dinnertime administration of a once daily dose of famotidine.Eur J Clin Pharmacol. 1988;35(2):203-7. doi: 10.1007/BF00609254. Eur J Clin Pharmacol. 1988. PMID: 3191940 Clinical Trial.
-
Single bedtime dose of famotidine: assessment of its antisecretory action by 24-hour intragastric pH monitoring.J Clin Pharmacol. 1987 Oct;27(10):790-3. doi: 10.1002/j.1552-4604.1987.tb02998.x. J Clin Pharmacol. 1987. PMID: 2892864 Clinical Trial.
-
Famotidine in the USA: a review of efficacy studies.J Int Med Res. 1989;17 Suppl 1:17A-24A. J Int Med Res. 1989. PMID: 2566539 Review.
-
Acid secretion and acid suppression in pathogenesis and healing of peptic ulcer disease.Hepatogastroenterology. 1990 Jul;37 Suppl 1:18-28. Hepatogastroenterology. 1990. PMID: 1976583 Review.
Cited by
-
Effect of food on H2-receptor blockade in normal subjects and duodenal ulcer patients.Gut. 1990 Feb;31(2):148-50. doi: 10.1136/gut.31.2.148. Gut. 1990. PMID: 2179066 Free PMC article. Clinical Trial.
-
Efficacy of primed infusions with high dose ranitidine and omeprazole to maintain high intragastric pH in patients with peptic ulcer bleeding: a prospective randomised controlled study.Gut. 1997 Jan;40(1):36-41. doi: 10.1136/gut.40.1.36. Gut. 1997. PMID: 9155573 Free PMC article. Clinical Trial.
-
Use of automatic computerised pump to maintain constant intragastric pH.Gut. 1990 Nov;31(11):1246-9. doi: 10.1136/gut.31.11.1246. Gut. 1990. PMID: 2253907 Free PMC article. Clinical Trial.
-
Rebound nocturnal hypersecretion after H2-receptor antagonist.Gut. 1989 Sep;30(9):1300-2. doi: 10.1136/gut.30.9.1300-a. Gut. 1989. PMID: 2572518 Free PMC article. No abstract available.
-
Effects of famotidine on upper gastrointestinal motility in patients with progressive systemic sclerosis.Gastroenterol Jpn. 1991 Apr;26(2):145-50. doi: 10.1007/BF02811072. Gastroenterol Jpn. 1991. PMID: 1645684 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources